Posted inMarket Legend Biotech Stock Maintained at Buy by H.C. Wainwright H.C. Wainwright maintains its buy rating for Legend Biotech, highlighting strong market positioning and ongoing growth potential. Posted by Prasenjit Bhowmik October 3, 2026